News & Events about Taro Pharmaceutical Industries Ltd.
Business Wire
5 months ago
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2023, filed with the Securities and Exchange Commission (the...
Ticker Report
6 months ago
Taro Pharmaceutical Industries (NYSE:TARO Get Rating) was downgraded by investment analysts at StockNews.com from a buy rating to a hold rating in a report released on Wednesday. Separately, HC Wainwright decreased their price objective on shares of Taro ...
StockNews.com downgraded shares of Taro Pharmaceutical Industries (NYSE:TARO Get Rating) from a buy rating to a hold rating in a research note issued to investors on Wednesday. Separately, HC Wainwright cut their price target on Taro Pharmaceutical Industries from $54.00 to $35.00 and set a buy ...
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the second quarter ended September 30, 2022, after the close of market on Thursday, October 27, 2022. The release will be accessible on Taros website at www.taro.com. About Taro Taro...